Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sucampo forms holding company to improve efficiency

This article was originally published in Scrip

Executive Summary

Sucampo Pharmaceuticals is to set itself up with a holding company to provide a more efficient corporate structure. After the changes, Sucampo Pharmaceuticals Inc will be the public company, with three wholly owned subsidiaries: Sucampo Pharma Ltd based in Tokyo and Osaka; Sucampo Pharma Americas Inc, based in Bethesda; andSucampo Pharma Europe, based in Oxford, UK, and Basel, Switzerland. Dr Sachiko Kuno, a co-founder of the company and a former CEO, will rejoin the board on completion of the changes. The company will also undertake a stock buyback of up to $10 million, and has promoted its acting chief financial officer, Jan Smilek, to CFO.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC007675

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel